Previous close | 15.83 |
Open | 15.77 |
Bid | 16.47 x 600 |
Ask | 16.58 x 100 |
Day's range | 15.70 - 17.12 |
52-week range | 9.50 - 19.09 |
Volume | |
Avg. volume | 1,269,266 |
Market cap | 1.588B |
Beta (5Y monthly) | 1.63 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call Transcript May 8, 2024 Avadel Pharmaceuticals plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to Avadel Pharmaceuticals First Quarter 2024 Earnings Call. At this time, all participants are […]
Insight into Avadel Pharmaceuticals' Q1 Financial Performance and Strategic Updates
The average of price targets set by Wall Street analysts indicates a potential upside of 28.6% in Avadel (AVDL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.